• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD face a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. There aren't enough data regarding how to get medication for adhd uk exposure over time may affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus don't develop neurological developmental disorders like impaired vision or hearing, febrile seizures, or IQ impairment. The authors acknowledge that further high-quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications must weigh the advantages of taking them against potential risks to the foetus. Doctors don't have the data needed to give clear guidelines, but they can provide information regarding risks and benefits that assist pregnant women in making informed decisions.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication in early pregnancy were not at a higher risk of fetal malformations or structural birth defects. Researchers used a vast population-based study of case-control to determine the prevalence of major structural birth defects in babies born to mothers who had taken stimulants during early pregnancy, and those who did not. Pediatric cardiologists, clinical geneticists and other experts looked over the cases to ensure that the classification was accurate and to eliminate any bias.

The study conducted by the researchers was not without its limitations. The researchers were unable to, in the first place, to separate the effects triggered by the medication from the disorder. This makes it difficult for researchers to establish whether the small associations observed among the groups that were exposed to medication use or if they were confounded by comorbidities. The researchers also did not look at long-term outcomes for the offspring.

The study revealed that infants whose mother had taken ADHD medication during pregnancy were at a slightly higher risk of admission to the neonatal care unit (NICU) in comparison to mothers who did not use any medication during pregnancy or quit taking the medication prior to or during pregnancy. This increase was due to central nervous system disorders, and the higher risk of admission did not appear to be influenced by which stimulant medication was used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher risk of having an emergency caesarean section or having the baby was not scoring well on the Apgar scale (less than 7). These increases appeared to be independent of the type of medication taken during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefit for both mother and child from continued treatment for the woman's condition. Doctors should discuss with their patients about this issue and, if possible, help them develop coping strategies that may reduce the effects of her disorder on her daily functioning and her relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and being treated with medication, the issue of whether to keep or discontinue treatment during pregnancy is a question that more and more doctors confront. These decisions are often made without clear and authoritative evidence. Instead, doctors must consider their own expertise and experience, as well as the experiences of other doctors, and the research on the topic.

Particularly, the subject of potential risks to the baby can be tricky. The research that has been conducted on this topic is based on observation rather than controlled studies and a lot of the results are in conflict. Most studies restrict their analysis to live-births, which could underestimate the teratogenic impact that can A general Physician prescribe adhd Medication lead to terminations or abortions of pregnancy. The study presented in this journal club addresses these limitations by examining data on both live and deceased births.

The conclusion is that while some studies have shown a positive association between liquid adhd medication medications and the risk of certain birth defects, others have found no connection, and most studies demonstrate a neutral or slightly negative effect. As a result, a careful risk/benefit analysis must be conducted in every instance.

For many women with ADHD who suffer from ADHD, the decision to stop taking medication can be difficult, if not impossible. In a recent article in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of loneliness. Additionally, the loss of medication can affect the ability to complete work-related tasks and safely drive which are essential aspects of a normal life for many people suffering from ADHD.

She suggests women who are unsure about whether or not to stop taking medication because of their pregnancy consider the possibility of educating friends, family members and colleagues about the condition, its impact on daily functioning, and on the benefits of keeping the current treatment plan. In addition, educating them can aid in ensuring that the woman feels supported in her struggle with her decision. It is important to remember that some medications can pass through the placenta, therefore, if a patient decides to discontinue her ADHD medication during pregnancy and breastfeeding, she should be aware of the possibility that traces of the drug could be transferred to the infant.

Risk of Birth Defects

As the use and misuse of ADHD medications to treat the symptoms of attention deficit disorder hyperactivity disorder (ADHD), increases as does the concern about the possible effects of the drugs on fetuses. A recent study published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. Researchers used two huge data sets to study more than 4.3 million pregnancies and determine if the use of stimulant medications caused birth defects. Researchers discovered that although the overall risk is low, the first trimester ADHD exposure to medication was associated with slightly higher risk of specific heart defects like ventriculoseptal defects.

The researchers of the study found no association between early medication use and other congenital anomalies, such as facial clefting or club foot. The results are consistent with previous studies showing an increase, but not significant, in the risk of cardiac malformations among women who started taking ADHD medications prior to the birth of their child. This risk increased in the latter half of pregnancy, when a lot of women begin to discontinue their medication.

Women who took ADHD medications during the first trimester of their pregnancy were also more likely to experience a caesarean section, a low Apgar score following delivery, and a baby that required breathing assistance at birth. However the researchers of the study were unable to eliminate bias due to selection by restricting the study to women who did not have other medical issues that could have contributed to the findings.

The researchers hope their research will aid in the clinical decisions of doctors who see pregnant women. They suggest that although the discussion of risks and benefits is important but the decision to stop or keep treatment should be based on the woman's requirements and the severity of her ADHD symptoms.

The authors caution that, although stopping the medication is a possibility to look into, it is not recommended due to the high prevalence of depression and other mental problems for women who are pregnant or recently gave birth. Further, the research suggests that women who choose to stop taking their medication are more likely to experience a difficult time adapting to life without them after the birth of their baby.

Nursing

It can be overwhelming becoming a mother. Women suffering from ADHD can face severe challenges when they have to manage their symptoms, attend doctor appointments and prepare for the birth of their child and adjust to new routines. Many women decide to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications pass through breast milk in very small amounts, therefore the risk for infant who is breastfeeding is low. The amount of exposure to medications will differ based on dosage the medication is administered, its frequency and the time of day. Additionally, different medications enter the baby’s system via the gastrointestinal tract, or through breast milk. The effect on the health of a newborn isn't completely known.

Because of the lack of evidence, some doctors might be tempted to stop taking stimulant drugs during a woman's pregnancy. This is a difficult choice for the patient, who must balance the benefits of continuing her medication against the possible dangers to the embryo. Until more information is available, doctors should inquire with all pregnant patients about their experience with ADHD and whether they are planning or taking to take medication during the perinatal time.

A growing number of studies have shown that women can continue taking their common adhd medications medication while they are pregnant and nursing. In the end, many patients choose to do so and in consultation with their doctor they have found that the benefits of maintaining their current medication far outweigh any potential risks.

It is crucial for women suffering from ADHD who are considering breastfeeding to seek a specialist psychiatrist's advice prior becoming pregnant. They should discuss their medication with their prescriber and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation is also needed to help pregnant women suffering from ADHD be aware of the symptoms and the underlying disorder. They should also be informed about treatment options and strengthen coping mechanisms. This should be a multidisciplinary approach including obstetricians, GPs, and psychiatry. Pregnancy counseling should include discussion of a treatment plan for the mother and the child, monitoring of indicators of deterioration, and, if needed adjustments to the medication regimen.